Life sciences R&D platform to expand product suite and fuel biotech breakthroughs tackling COVID-19 to cancer to climate change SAN FRANCISCO, May 28, 2020-- Benchling, the leading life sciences R&D cloud platform, announced it closed $50 million in Series D funding led by Alkeon and joined by new investors Spark Capital, Lux Capital and ICONIQ Partners, as well as existing investors Thrive Capital, Benchmark and Menlo Ventures.